Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Stimulated CD4+ T lymphocytes can differentiate into effector T cell (Teff) or inducible regulatory T cell (Treg) subsets with specific immunological roles. We show that Teff and Treg require distinct metabolic programs to support these functions. Th1, Th2, and Th17 cells expressed high surface levels of the glucose transporter Glut1 and were highly glycolytic. Treg, in contrast, expressed low levels of Glut1 and had high lipid oxidation rates. Consistent with glycolysis and lipid oxidation promoting Teff and Treg, respectively, Teff were selectively increased in Glut1 transgenic mice and reliant on glucose metabolism, whereas Treg had activated AMP-activated protein kinase and were dependent on lipid oxidation. Importantly, AMP-activated protein kinase stimulation was sufficient to decrease Glut1 and increase Treg generation in an asthma model. These data demonstrate that CD4+ T cell subsets require distinct metabolic programs that can be manipulated in vivo to control Treg and Teff development in inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In contrast to Treg cells, TH2 cells were shown to display an increased glycolytic rate44.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“This increased mitochondrial metabolism in Tregs was found to be due to increased AMPK-dependent fatty acid oxidation (MacIver et al., 2011; Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
The cited source says what the claim attributes to it.
In the citing paper
“Different subsets of T cells, as well as different stages following T cell activation, are characterized by the use of different metabolic pathways [97, 108, 109].”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [108]
In the citing paper
“Tregs have elevated levels of oxidative phosphorylation and decreased glycolytic flux compared to Th17 cells (Michalek et al., 2011).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Michalek et al., 2011
In the citing paper
“This was first demonstrated by Michalek et al. (34), who determined that proinflammatory CD4+ T helper (TH) cells (TH1, TH2, and TH17 lineages) displayed a strong bias toward glycolysis over mitochondrial metabolism, whereas induced CD4+ T regulatory (Treg) lineage cells displayed a mixed metabolism involving glycolysis, lipid oxidation, and OXPHOS.”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088 · cited 1×
“To meet these requirements, activated T cells decrease lipid oxidation and undergo a rapid increase in glycolysis (4).”
BackgroundmTOR regulates memory CD8 T-cell differentiation
Araki, K., Turner, A. P., Shaffer, V. O., Gangappa, S., Keller, S. A., Bachmann, M. F., Larsen, C. P., & Ahmed, R. (2009) · Nature · doi:10.1038/nature08155 · Cited by 1,575 · cited 2×
“At the conclusion of an immune response, decreased glycolysis and increased lipid oxidation can favor the enrichment of long-lived CD8 memory cells (5, 6).”
BackgroundEnhancing CD8 T-cell memory by modulating fatty acid metabolism
Pearce, E. L., Walsh, M. C., Cejas, P. J., Harms, G. M., Shen, H., Wang, L.-S., Jones, R. G., & Choi, Y. (2009) · Nature · doi:10.1038/nature08097 · Cited by 1,559 · cited 4×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodInfluentialThe mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage Commitment
Delgoffe, G. M., Kole, T. P., Zheng, Y., Zarek, P. E., Matthews, K. L., Xiao, B., Worley, P. F., Kozma, S. C., & Powell, J. D. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.014 · Cited by 1,284
Jacobs, S. R., Herman, C. E., MacIver, N. J., Wofford, J. A., Wieman, H. L., Hammen, J. J., & Rathmell, J. C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4476 · Cited by 850 · cited 5×
“1G) and Ig deposition in the kidneys (3).”
BackgroundSelf-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813 · cited 1×
“In contrast, the AMPK pathway acts to inhibit mTOR by suppressing mTOR signaling and to promote mitochondrial oxidative metabolism rather than glycolysis (10).”
BackgroundThe AKT–mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells
Haxhinasto, S., Mathis, D., & Benoist, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071477 · Cited by 737 · cited 1×
“Inhibition of mTOR can result in the elevated oxidation of exogenous FA (15) and promote Treg differentiation (16).”
BackgroundStability of the Regulatory T Cell Lineage in Vivo
Rubtsov, Y. P., Niec, R. E., Josefowicz, S., Li, L., Darce, J., Mathis, D., Benoist, C., & Rudensky, A. Y. (2010) · Science · doi:10.1126/science.1191996 · Cited by 730 · cited 1×
“stable pool of important immune regulatory cells (18), and lipid oxidation may be central in contributing to their maintenance and self-renewal.”
BackgroundWieman, H. L., Wofford, J. A., & Rathmell, J. C. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0593 · Cited by 593 · cited 3×
“Glucose uptake, glycolysis, and lipid oxidation were measured as previously described (5, 7, 13).”
BackgroundMethodSelf-citation
Cited by
Items 701–800 of 1,005
Extracellular citrate and metabolic adaptations of cancer cells
Parkinson, E. K., Adamski, J., Zahn, G., Gaumann, A. K. A., Flores‐Borja, F., Ziegler, C. M., & Mycielska, M. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10007-1 · Cited by 53
Sun, C., Liang, H., Zhao, Y., Li, S., Li, X., Yuan, X., Cheng, G., Zhang, Y., Liu, M., Guan, Y., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115913 · Cited by 54
Chen, X., Liu, L., Kang, S., Gnanaprakasam, J. R., & Wang, R. (2023) · Science Advances · doi:10.1126/sciadv.add9554 · Cited by 57
“We and others have previously shown that T H 17 cells sustain high glycolysis, and inhibiting glycolysis suppresses T H 17 cell differentiation ( 8 , 16 , 17 ).”
Targeting the metabolism of tumor-infiltrating regulatory T cells
Wang, Y., Huang, T., Gu, J., & Lu, L. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.06.001 · Cited by 62
Hu, H., Li, H., Li, R., Liu, P., & Liu, H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05450-x · Cited by 71
Bioenergetics profile of CD4 + T cells in relapsing remitting multiple sclerosis subjects
Riccardis, L. D., Rizzello, A., Ferramosca, A., Urso, E., Robertis, F. D., Danieli, A., Giudetti, A. M., Trianni, G., Zara, V., & Maffia, M. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.02.015 · Cited by 54
Palmer, C. S., Henstridge, D. C., Yu, D., Singh, A., Balderson, B., Duette, G., Cherry, C. L., Anzinger, J. J., Ostrowski, M., & Crowe, S. M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1600120 · Cited by 61
“Researchers performing studies in human T cells do not have the luxury of Myc tagging and must rely on binding of Glut1 Abs to Glut1.”
BackgroundInfluentialHigh density lipoproteins selectively promote the survival of human regulatory T cells
Rueda, C. M., Rodríguez-Perea, A. L., Moreno-Fernandez, M., Jackson, C. M., Melchior, J. T., Davidson, W. S., & Chougnet, C. A. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m072835 · Cited by 52
“Importantly, FAs derive from extrinsic sources, and both short-chain FAs (propionate, butyrate, and acetate) and exogenous long-chain FAs (oleate/palmitate) can be used as fuel and are important metabolites for Treg homeostasis (5, 26).”
BackgroundInfluentialCell-Intrinsic Roles for Autophagy in Modulating CD4 T Cell Functions
Jacquin, É., & Apétoh, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01023 · Cited by 54
Bahrambeigi, S., & Shafiei‐Irannejad, V. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113787 · Cited by 52
Metabolic determinants of lupus pathogenesis
Teng, X., Brown, J., Choi, S., Li, W., & Morel, L. M. (2020) · Immunological Reviews · doi:10.1111/imr.12847 · Cited by 56
Metabolic Targets for Treatment of Autoimmune Diseases
Piranavan, P., Bhamra, M. S., & Perl, A. (2020) · Immunometabolism · doi:10.20900/immunometab20200012 · Cited by 57
“hyperpolarization [3] and block in electron transport [4] occur with increased production of reactive oxygen intermediates (ROI) and the depletion of antioxidant metabolites, such as reduced glutathione [3].”
BackgroundDeciphering Natural Killer Cell Homeostasis
Pfefferle, A., Jacobs, B., Haroun-Izquierdo, A., Kveberg, L., Sohlberg, E., & Malmberg, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00812 · Cited by 65
FXR mediates T cell-intrinsic responses to reduced feeding during infection
Campbell, C., Marchildon, F., Michaels, A. J., Takemoto, N., van der Veeken, J., Schizas, M., Pritykin, Y., Leslie, C. S., Intlekofer, A. M., Cohen, P., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020619117 · Cited by 50
NLRX1 Regulates Effector and Metabolic Functions of CD4+ T Cells
Leber, A. J., Hontecillas, R., Tubau‐Juni, N., Zoccoli-Rodriguez, V., Hulver, M. W., McMillan, R. P., Eden, K. B., Allen, I. C., & Bassaganya-Riera, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601547 · Cited by 60
“In contrast to Tregs, effector CD4 T cells have an established preference for energy production through the LDH pathway (21).”
BackgroundImpact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
Cohen, I., & Blasberg, R. G. (2017) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223417731565 · Cited by 69
An immunometabolic pathomechanism for chronic obstructive pulmonary disease
Bruzzaniti, S., Bocchino, M., Santopaolo, M., Calì, G., Stanziola, A. A., D’Amato, M., Esposito, A., Barra, E., Garziano, F., Micillo, T., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906303116 · Cited by 52
Selenoproteins as regulators of T cell proliferation, differentiation, and metabolism
Ma, C., & Hoffmann, P. R. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.11.006 · Cited by 56
Mitochondrial functionality and metabolism in T cells from progressive multiple sclerosis patients
Biasi, S. D., Simone, A. M., Bianchini, E., Tartaro, D. L., Pecorini, S., Nasi, M., Patergnani, S., Carnevale, G., Gibellini, L., Ferraro, D., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201948223 · Cited by 58
Kang, S., & Tang, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.572677 · Cited by 61
“Effector CD4+ T cells including Th1, Th2, and Th17 mainly rely on aerobic glycolysis to fuel immune response while the anti-inflammatory regulatory T (Treg) cells oxidize fatty acids as an energy source (38, 39).”
BackgroundT cell metabolism in homeostasis and cancer immunity
Wei, J., Zheng, W., Chapman, N. M., Geiger, T. L., & Chi, H. (2021) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.02.003 · Cited by 59
“Treg cells have distinct glycolytic and mitochondrial metabolism from effector CD4+ T cells [18,19].”
BackgroundProstate Cancer Progression: as a Matter of Fats
Scaglia, N., Frontini-López, Y. R., & Zadra, G. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.719865 · Cited by 55
Metabolism in the progression and metastasis of brain tumors
Tyagi, A., Wu, S.-Y., & Watabe, K. (2022) · Cancer Letters · doi:10.1016/j.canlet.2022.215713 · Cited by 63
Wu, D., Hu, L., Han, M., Deng, Y., Zhang, Y., Ren, G., Zhao, X., Li, Z., Li, P., Zhang, Y., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00595-9 · Cited by 53
Reactive oxygen species formation and its effect on CD4+ T cell-mediated inflammation
Shu, P., Liang, H., Zhang, J., Lin, Y., Chen, W., & Zhang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1199233 · Cited by 66
The role of nuclear receptors in regulation of Th17/Treg biology and its implications for diseases
Park, B. V., & Pan, F. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.21 · Cited by 52
Raha, S., Raud, B., Oberdörfer, L., Castro, C. N., Schreder, A., Freitag, J., Longerich, T., Lochner, M., Sparwasser, T. D., Berod, L., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546152 · Cited by 53
mTOR: A double-edged sword for diabetes
Tuo, Y., & Xiang, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0317-095rr · Cited by 53
Choi, H., & Na, K. J. (2018) · Theranostics · doi:10.7150/thno.23767 · Cited by 73
“As T cell activation requires upregulated glucose metabolism similar to cancer cells to permit proliferation and differentiation into effector T cells [29], the glucose competition between cancer cells and tumor-infiltrating lymphocytes can influence immune cell differentiation and composition in the TME.”
Hexokinase 2 is dispensable for T cell-dependent immunity
Mehta, M., Weinberg, S. E., Steinert, E. M., Chhiba, K. D., Martinez, C. A., Gao, P., Perlman, H., Bryce, P. J., Hay, N., & Chandel, N. S. (2018) · Cancer & Metabolism · doi:10.1186/s40170-018-0184-5 · Cited by 59
Immunometabolism: A new target for improving cancer immunotherapy
Guo, C., Chen, S., Liu, W., Ma, Y., Li, J., Fisher, P. B., Fang, X., & Wang, X. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.03.004 · Cited by 59
“…in suppressive immune cells Although the metabolic conditions in the TME dampen antitumor function of tumor-specific effector T cells, Tregs can continue to exert their immunosuppressive effect due to their metabolic reliance on FAO (MacIver, Michalek, & Rathmell, 2013; Michalek et al., 2011).”
BackgroundTNFR2: Role in Cancer Immunology and Immunotherapy
Yang, Y., Islam, M. S., Hu, Y., & Chen, X. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s255224 · Cited by 58
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
Nair, V. S., Saleh, R., Toor, S. M., Cyprian, F. S., & Elkord, E. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02842-y · Cited by 60
The COVIDome Explorer researcher portal
Sullivan, K. D., Galbraith, M. D., Kinning, K. T., Bartsch, K. W., Levinsky, N., Araya, P., Smith, K. P., Granrath, R. E., Shaw, J. R., Baxter, R. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109527 · Cited by 48
“Increased glycolysis is a metabolic consequence of both immune cell activation and hypoxemia (Makowski et al., 2020; Frauwirth et al., 2002; Michalek et al., 2011; Jellusova, 2020; van Teijlingen Bakker and Pearce, 2020).”
Bishop, E. L., Gudgeon, N. H., Fulton-Ward, T., Stavrou, V., Roberts, J., Boufersaoui, A., Tennant, D. A., Hewison, M., Raza, K., & Dimeloe, S. (2024) · Science Signaling · doi:10.1126/scisignal.adg5678 · Cited by 53
Metabolic Regulation of Regulatory T Cell Development and Function
Coe, D., Kishore, M., & Marelli‐Berg, F. M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00590 · Cited by 51
Novel Therapeutic Targets of Tumor Metabolism
Kishton, R. J., & Rathmell, J. C. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000099 · Cited by 50
Self-citationCusanovich, D. A., Billstrand, C., Zhou, X., Chavarria, C., De Leon, S., Michelini, K., Pai, A. A., Ober, C., & Gilad, Y. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds021 · Cited by 49
“In addition, cellular proliferation, a central process of the lymphocyte response to antigen, is energetically taxing, and there is evidence suggesting that the metabolic pathways activated in T cells can influence not only sensitivity to apoptotic signals, but lineage decisions as well (58,59).”
BackgroundAl-Khami, A. A., Ghonim, M. A., Valle, L. D., Ibba, S. V., Zheng, L., Pyakurel, K., Okpechi, S. C., Garay, J., Wyczechowska, D. D., Sanchez‐Pino, M. D., et al. (2017) · Clinical & Experimental Allergy · doi:10.1111/cea.12947 · Cited by 50
“In fact, reports have shown that the inhibition of FAO restrains Treg cell differentiation and function.(7,29,30) This is intriguing because, although Treg cells are known to control asthma,(31,32) the net result of FAO inhibition appears to be a reduced allergic inflammatory response.”
Backgroundvan de Wetering, C., Aboushousha, R., Manuel, A. M., Chia, S. B., Erickson, C. S., MacPherson, M. B., van der Velden, J. L. J., Anathy, V., Dixon, A. E., Irvin, C. G., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1901086 · Cited by 52
“activation (23) and to promote T cell effector function (21).”
BackgroundLactate in Sarcoma Microenvironment: Much More than just a Waste Product
Taddei, M. L., Pietrovito, L., Leo, A., & Chiarugi, P. (2020) · Cells · doi:10.3390/cells9020510 · Cited by 51
“CD4+ T cells may, in turn, activate or inhibit other downstream immune cells, modulating the immune response against cancer [106] TAMs are the main component of immune infiltrate in several tumours.”
BackgroundDeterminants of Tissue-Specific Metabolic Adaptation of T Cells
Varanasi, S. K., Kumar, S. V., & Rouse, B. T. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.013 · Cited by 48
“Interestingly, skin Treg cells express either PPARα/γ isoforms whereas, adipose-tissue-specific Tregs express only PPARγ.”
BackgroundInfluentialZhao, Q. S., Duck, L. W., Huang, F., Alexander, K. L., Maynard, C. L., Mannon, P., & Elson, C. O. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc6373 · Cited by 54
Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
Xiao, C., Tian, H., Zheng, Y., Yang, Z., Li, S., Fan, T. T., Xu, J., Bai, G., Liu, J., Deng, Z., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1013885 · Cited by 58
“HIF-1α also favors an immunosuppressive TME by reinforcing other cancerpromoting immune cell functions, including MDSCs and M2like macrophages (Deng et al., 2019; Zhang et al., 2022).”
BackgroundInfluentialXin, X., Wang, Q., Qing, J., Song, W., Gui, Y., Li, X., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974648 · Cited by 48
Molecular Mechanisms of T Helper Cell Differentiation and Functional Specialization
Lee, G. R. (2023) · Immune Network · doi:10.4110/in.2023.23.e4 · Cited by 64
“Fatty acid oxidation is essential for Treg cell generation and function, and for making membrane components by proliferating effector T cells, including Th1, Th2, and Th17 cells (70).”
BackgroundBeyond Cancer Cells: How the Tumor Microenvironment Drives Cancer Progression
Sabit, H., Arneth, B. M., Abdel-Ghany, S. E., Madyan, E. F., Ghaleb, A. H., Selvaraj, P., Shin, D. M., Bommireddy, R., & El-Hashash, A. H. K. (2024) · Cells · doi:10.3390/cells13191666 · Cited by 58
“Elevated levels of lactate and kynurenine in the TME are known to enhance the immunosuppressive functions of regulatory T-cells, enabling them to dominate over CD8 effector cells [18].”
BackgroundAt the crossroad of T cells, adipose tissue, and diabetes
Matarese, G., Procaccini, C., & Rosa, V. D. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01154.x · Cited by 52
Hwang, S., Li, X., Lu, Y., Jin, Y., Jeong, Y., Kim, Y. D., Lee, I., Taketomi, Y., Sato, H., Cho, Y. S., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.02.018 · Cited by 48
mTOR Regulation of Lymphoid Cells in Immunity to Pathogens
Keating, R., & McGargill, M. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00180 · Cited by 51
Protein Kinase CK2 Controls the Fate between Th17 Cell and Regulatory T Cell Differentiation
Gibson, S. A., Yang, W., Yan, Z., Liu, Y., Rowse, A. L., Weinmann, A. S., Qin, H., & Benveniste, E. N. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601912 · Cited by 47
“Recent studies have highlighted the importance of metabolism in the induction of CD4 T cell phenotypes (41, 42).”
BackgroundExploring Non-Metabolic Functions of Glycolytic Enzymes in Immunity
Seki, S. M., & Gaultier, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01549 · Cited by 48
Sabapathy, V., Stremska, M., Mohammad, S., Corey, R., Sharma, P. R., & Sharma, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00572 · Cited by 45
“Interestingly, Tregs have been shown to favor oxidative phosphorylation and fatty acid oxidation (Michalek et al., 2011; Priyadharshini et al., 2018) for metabolism, yet the hyperlipidemic animals in our current study and T2D patients (Wagner et al., 2013) had reduced Treg levels.”
A Novel Role for Triglyceride Metabolism in Foxp3 Expression
Howie, D., ten Bokum, A., Cobbold, S. P., Yu, Z., Kessler, B. M., & Waldmann, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01860 · Cited by 48
Lactate: Fueling the fire starter
Certo, M., Marone, G., de Paulis, A., Mauro, C., & Pucino, V. (2019) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1474 · Cited by 54
“…different metabolic requirements; with cytotoxic and effector T cells being more dependent on glycolysis for proliferation and cytokine production (Macintyre et al., 2014), while regulatory T cells (Tregs) rely more on oxidative phosphorylation (Gerriets et al., 2015; Michalek et al., 2011).”
BackgroundImmune metabolism regulation of the germinal center response
Choi, S., & Morel, L. M. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0392-2 · Cited by 54
Mohammed, A. K., Alghetaa, H., Miranda, K., Wilson, K. M., Singh, N. P., Cai, G., Putluri, N., Nagarkatti, P. S., & Nagarkatti, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176244 · Cited by 56
“This observation indicates that THC stunts cell growth based on a previous study which showed that T cell growth and function requires rapid increases in glycolysis and a decrease in lipid metabolism [55].”
Metabolic substrate utilization in stress-induced immune cells
Zhang, X., Zink, F., Hezel, F., Vogt, J. A., Wachter, U. A., Wepler, M., Loconte, M., Kranz, C., Hellmann, A., Mizaikoff, B., et al. (2020) · Intensive Care Medicine Experimental · doi:10.1186/s40635-020-00316-0 · Cited by 54
Caicedo, A., Zambrano, K., Sanon, S., Luis Vélez, J., Montalvo, M., Jara, F., Moscoso, S. A., Vélez, P., Maldonado, A., & Velarde, G. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.02.014 · Cited by 48
Hong, M. M. Y., & Vareki, S. M. (2022) · Cancers · doi:10.3390/cancers14061580 · Cited by 55
“In contrast, Tregs use oxidative phosphorylation (OXPHOS) and fatty acid oxidation [78,79].”
BackgroundEnergy metabolism and rheumatic diseases: from cell to organism
Spies, C. M., Straub, R. H., & Buttgereit, F. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3885 · Cited by 47
“In an asthma model, AMPK stimulation was sufficient to decrease Glut1 and increase Treg generation, indicating that the distinct metabolic programs can be modulated in vivo [44].”
BackgroundOverview: Lipid Metabolism in the Tumor Microenvironment
Ma, K., & Zhang, L. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-33-6785-2_3 · Cited by 51
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 56
Wang, R., Zhuang, J., Zhang, Q., Wu, W., Yu, X., Zhang, H., & Xie, Z. (2025) · Experimental Hematology and Oncology · doi:10.1186/s40164-025-00689-6 · Cited by 60
The therapeutic potential of epigenetic manipulation during infectious diseases
Cole, J., Morris, P., Dickman, M. J., & Dockrell, D. H. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.07.013 · Cited by 52
“Both the AMP activated protein kinase (AMPK) and mTOR are the key in controlling T-cell metabolic activity (Michalek et al., 2011).”
BackgroundImmunometabolism, pregnancy, and nutrition
Thiele, K., Diao, L., & Arck, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0660-y · Cited by 52
“In contrast, overweight and overnutrition can shift this balance towards elevated immune cells activation and inflammation due to increased leptin and reduced adiponectin levels which lead to accumulation of proinflammatory effector T (Teff) cells, reduced number of Tregs and downregulation of IL-10 production in DCs.”
InfluentialCancer, obesity and immunometabolism – Connecting the dots
Dyck, L., & Lynch, L. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.12.019 · Cited by 51
Metabolic Checkpoints in Differentiation of Helper T Cells in Tissue Inflammation
Roy, S., Rizvi, Z. A., & Awasthi, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03036 · Cited by 50
T cell-specific deletion of Pgam1 reveals a critical role for glycolysis in T cell responses
Toriyama, K., Kuwahara, M., Kondoh, H., Mikawa, T., Takemori, N., Konishi, A., Yorozuya, T., Yamada, T., Soga, T., Shiraishi, A., et al. (2020) · Communications Biology · doi:10.1038/s42003-020-01122-w · Cited by 56
Mitochondrial metabolism is essential for invariant natural killer T cell development and function
Weng, X., Kumar, A., Cao, L., He, Y. Z., Morgun, E., Visvabharathy, L., Zhao, J., Sena, L. A., Weinberg, S. E., Chandel, N. S., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021385118 · Cited by 48
“As activated T cells progress to a memory or regulatory phenotype, they preferentially oxidize fatty acids to support mitochondrial metabolism, and enhanced fatty acid oxidation (FAO) and spare respiratory capacity (SRC) are essential to maintenance of their phenotype (6, 7).”
BackgroundThe Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells
Lochner, M., Wang, Z., & Sparwasser, T. D. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.013 · Cited by 53
Immunometabolism – The Role of Branched-Chain Amino Acids
Yahsi, B., & Günaydın, G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886822 · Cited by 51
Hurrell, B. P., Helou, D. G., Howard, E. D., Painter, J. D., Shafiei-Jahani, P., Sharpe, A. H., & Akbari, O. (2022) · Nature Communications · doi:10.1038/s41467-022-32899-5 · Cited by 52
Kim, D., Kim, G., Yu, R., Lee, J., Kim, S., Gleason, M. R., Qiu, K., Montauti, E. I., Wang, L. L., Fang, D., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.08.008 · Cited by 57
Gan, M., Liu, N., Li, W., Chen, M., Bai, Z., Liu, D., & Liu, S. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02193-7 · Cited by 62
Does the PI3K pathway promote or antagonize regulatory T cell development and function?
Soond, D. R., Slack, E. C. M., Garden, O. A., Patton, D. T., & Okkenhaug, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00244 · Cited by 46
“By inhibiting mTORdependent glycolysis in favor of lipid oxidation, rapamycin may favor the expansion of Tregs (Michalek et al., 2011; Shi et al., 2011).”
BackgroundMitochondrial Control and Guidance of Cellular Activities of T Cells
Chao, T. H., Wang, H., & Ho, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00473 · Cited by 52
Craveiro, M., Cretenet, G., Mongellaz, C., Matias, M. I., Caron, O., de Lima, M. C. P., Zimmermann, V. S., Solary, É., Dardalhon, V., Dulić, V., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal3024 · Cited by 52
Kalim, K. W., Yang, J., Li, Y., Meng, Y., Zheng, Y., & Guo, F. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1601765 · Cited by 53
Sirtuin-1 in immunotherapy: A Janus-headed target
Chadha, S., Wang, L., Hancock, W. W., & Beier, U. H. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.2ru1118-422r · Cited by 52
Huang, M., Xiong, D., Pan, J., Zhang, Q., Wang, Y., Myers, C. R., Johnson, B. D., Hardy, M., Kalyanaraman, B., & You, M. (2022) · Advanced Science · doi:10.1002/advs.202101267 · Cited by 51
Meng, F., Yu, W., Duan, W., Wang, T., & Liu, Y. (2019) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12528 · Cited by 45
The Role of Metabolic Enzymes in the Regulation of Inflammation
Godfrey, W. H., & Kornberg, M. D. (2020) · Metabolites · doi:10.3390/metabo10110426 · Cited by 51
“At the same time, FAO is important for a memory phenotype, with IL-15, a cytokine that is critical for the generation of CD8+ memory T cells, promoting FAO by increasing mitochondrial Metabolites 2020, 10, 426 10 of 22 biogenesis and increasing the expression of carnitine palmitoyl transferase (CPT1a), the rate-limiti…”
BackgroundInfluentialKohoutková, M. H., Lázničková, P., & Frič, J. (2020) · BioEssays · doi:10.1002/bies.202000067 · Cited by 50
“Generally speaking, long-lived cells, such as memory T cells and Treg [32,33] have relatively low biosynthetic demands and use FAO and OXPHOS to generate energy.”
BackgroundInfluentialObesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back
Schmidt, V., Hogan, A. E., Fallon, P. G., & Schwartz, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932893 · Cited by 54
Metabolic dysregulation of lymphocytes in autoimmune diseases
Wang, S., Yang, N., & Zhang, H. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.01.005 · Cited by 53
Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?
Kim, J., Li, J., Wei, J., & Lim, S. A. (2025) · Immune Network · doi:10.4110/in.2025.25.e13 · Cited by 53
“This metabolic shift is accompanied by signaling changes, including AMPK activation, and mTORC1 suppression (46).”
The Untapped Opportunity and Challenge of Immunometabolism: A New Paradigm for Drug Discovery
Mazumdar, C., Driggers, E. M., & Turka, L. A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.014 · Cited by 50
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 53
Fatty acid metabolism in T-cell function and differentiation
Endo, Y., Kanno, T., & Nakajima, T. (2022) · International Immunology · doi:10.1093/intimm/dxac025 · Cited by 54
Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy
Li, W., Pan, X., Chen, L., Cui, H., Mo, S., Pan, Y., Shen, Y., Shi, M., Wu, J., Luo, F., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1186383 · Cited by 60
The Role of Tumor Metabolic Reprogramming in Tumor Immunity
Zhang, X., Song, W., Gao, Y., Zhang, Y., Zhao, Y., Hao, S., & Ni, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417422 · Cited by 54
Matched and mismatched metabolic fuels in lymphocyte function
Caro-Maldonado, A., Gerriets, V. A., & Rathmell, J. C. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.002 · Cited by 44
Self-citationThe Role of FOXP3 in Regulating Immune Responses
Vent‐Schmidt, J., Han, J. M., MacDonald, K. G., & Levings, M. K. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2013.811657 · Cited by 51
“Indeed, Tregs seem to rely on the AMPK pathway to perform lipid oxidation, and thus pharmacological activation of AMPK may enhance the maintenance of Tregs [78].”
BackgroundLipid-driven immunometabolic responses in atherosclerosis
Gisterå, A., & Ketelhuth, D. F. J. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000540 · Cited by 44
Regulation of T cell immunity by cellular metabolism
Hu, Z., Zou, Q., & Su, B. (2018) · Frontiers of Medicine · doi:10.1007/s11684-018-0668-2 · Cited by 47
Cellular Metabolic Regulation in the Differentiation and Function of Regulatory T Cells
Chen, Y., Colello, J., Jarjour, W. N., & Zheng, S. G. (2019) · Cells · doi:10.3390/cells8020188 · Cited by 52
“Moreover, glycolysis inhibits Tregs differentiation and promotes Tregs expansion, whereas fatty-acid oxidation (FAO) promotes Tregs differentiation [15,17].”
BackgroundLeber, A. J., Hontecillas, R., Zoccoli-Rodriguez, V., Bienert, C., Chauhan, J., & Bassaganya-Riera, J. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900364 · Cited by 48
“Immune cells unable to establish fatty acid metabolism can show insensitivity to regulatory and suppressive signals (32).”
BackgroundAge‐related factors that affect B cell responses to vaccination in mice and humans
Frasca, D., Blomberg, B. B., Garcia, D., Keilich, S. R., & Haynes, L. (2020) · Immunological Reviews · doi:10.1111/imr.12864 · Cited by 47
Host-Directed Therapy in Tuberculosis: Targeting Host Metabolism
Kim, J., Kim, Y.-R., & Yang, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01790 · Cited by 53
Metadata
- Authors
- Michalek, R. D., Gerriets, V. A., Jacobs, S. R., Macintyre, A. N., MacIver, N. J., Mason, E. F., Sullivan, S. A., Nichols, A. G., & Rathmell, J. C.
- Affiliations
- Duke University (US)
- Duke Medical Center (US)
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 186
- Issue
- 6
- Pages
- 3299-3303
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC3198034
- OpenAlex
- W2157739158
- Cited by
- 2,091
- References
- 18
- Citations by year
- 2026: 116 · 2025: 133 · 2024: 168 · 2023: 163 · 2022: 214 · 2021: 215 · 2020: 209 · 2019: 167 · 2018: 147 · 2017: 164 · 2016: 122 · 2015: 88 · 2014: 69 · 2013: 55 · 2012: 47
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- Cancer Research Institute
- Lupus Research Institute
- Leukemia and Lymphoma Society
- American Asthma Foundation
- Lupus Research Alliance
- National Institutes of Health
- University of California, San Francisco
- National Heart, Lung, and Blood Institute (R01HL108006)
- National Institute of Allergy and Infectious Diseases (R01AI063345)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- effector T cells, regulatory T cells, glycolysis, lipid oxidation, glucose transporter 1, AMPK, Th1 cells, Th2 cells, Th17 cells, asthma, Treg generation, inflammatory diseases
- MeSH terms
- Animals, Asthma, Cell Survival, Cells, Cultured, Disease Models, Animal, Glycolysis, T-Lymphocytes, Helper-Inducer, Mice, Inbred C57BL, Mice, Transgenic, Lipid Peroxidation, Immunophenotyping, T-Lymphocyte Subsets, T-Lymphocytes, Regulatory, Glucose Transporter Type 1, Mice, AMP-Activated Protein Kinases, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.